期刊文献+

用液相色谱-质谱-质谱法测定人血清中非洛地平浓度 被引量:3

Quantitative determination of felodipine in human serum by LC-MS-MS method
下载PDF
导出
摘要 目的:建立液相色谱-质谱-质谱(LC-MS-MS)法测定人血清中非洛地平的浓度。方法:血清样品经液-液萃取预处理。色谱柱为Xterra柱(50 mm×2.1 mm,3.5μm),流动相为乙腈-0.02%氨水,采用梯度洗脱,流速为0.3 mL/min。非洛地平和尼莫地平(内标)的多反应监测(MRM)扫描离子对分别为m/z382.1→145和m/z417.2→92,两者的保留时间分别为1.24 min和1.06 min。结果:非洛地平在0.04~20 ng/mL范围内线性关系良好(r=0.999 7),低、中、高浓度(0.08、8.0、16.0 ng/mL)的日内RSD分别为6.60%、7.22%和5.01%(n=6),日间RSD分别为9.42%、8.46%和5.12%(n=14),准确度为98.21%~106.20%(n=6)。结论:本法操作简便,检测准确、灵敏、专一,重复性好,适用于非洛地平血药浓度监测和药动学及生物利用度研究。 Objective: To establish a LC-MS-MS method for determining the concentration of felodipine in human serum. Methods:The serum samples were pretreated by liquid-liquid extraction. The chromatographic column was a Xterra column (50 mm×2.1 mm, 3.5 μm). The mobile phase consisting of acetonitrile-0.02% ammonia water was eluted at a flow rate of 0.3 mL/min with gradient program. Felodipine and its internal standard nimodipine was monitored in multiple reaction monitoring(MRM) mode. The fragmentation transitions from precursor to production were m/z 382. 1/145 for felodipine and m/z 417.2/92 for nimodipine. The retention time of felodipine and nimodipine was 1.24 and 1.06 min, respectively. Results: For felodipine, the linear range was 0.04-20 ng/mL (r= 0. 999 7). At low, middle and high concentrations(0.08,8.0,16.0 ng/mL), the intra-day RSDs were 6. 60%,7. 22% and 5.01% (n=6) ,the inter-day RSDs were 9. 42%,8. 46% and 5. 12%(n= 14) ,and the accuracy rates were 98.2%- 106.20%( n = 6 ). Conclusion: This method is simple, accurate, sensitive, specific and reproducible for the determination of felodipine in human serum. It is suitable for therapeutic drug monitoring,pharmacokinetic and bioavailability study of felodipine.
出处 《药学服务与研究》 CAS CSCD 2007年第4期253-255,共3页 Pharmaceutical Care and Research
关键词 非洛地平 色谱法 高压液相 光谱分析 质量 血药浓度 felodipine chromatography, high pressure liquid spectrum analysis, mass plasma concentration
  • 相关文献

参考文献7

二级参考文献16

  • 1丁养军,尤进茂.序贯单纯形法确定高效液相色谱流动相各组分的最佳配比[J].色谱,1995,13(6):475-478. 被引量:14
  • 2Dru J D,J Chromatogr B,1995年,666卷,259页
  • 3徐积恩,中国新药杂志,1992年,1卷,26页
  • 4Nishioka R,J Chromatogr B,1991年,565卷,237页
  • 5刘皋林,国外医药.合成药、生化药、制剂分册,1991年,12卷,96页
  • 6徐晋,中国药理学通报,1990年,6卷,52页
  • 7刘昌孝,孙瑞元.药代动力学研究[A].见:刘昌孝,孙瑞元,主编.药物评价实验设计与统计学基础[M].北京:军事医学科学出版社,1999:127-8
  • 8Nishioka R, Umeda I, Qi NB. Determination of felodipine and its metabolites in plasma using capillary gas chromatography with electron-capture detection and their identification by gas chromatography-mass spectrometry [ J]. J Chromatogr B: Biomed Appl,1991 ;565:237 - 41
  • 9Dru JD, Hsieh JY, Matuszewski BK, Dobrinska MR. Determination of felodipine, its enantioners, and a pyridine in human plasma by capillary gas chromatography with mass-spectroetric detection[ J]. J Chromatogr B: Biomed Appl, 1995; 666: 259 - 67
  • 10U. S. Department of Health and Human Services, Food and Drug Administration. Guidance for industry: Bioanalyticai method validation[ S ]. 2001.4 - 10.

共引文献27

同被引文献23

  • 1原巧灵,牛青英,赵焕兰.动态血压监测评价不同时间服用非洛地平的降压效应[J].临床医药实践,2007,16(9):811-813. 被引量:2
  • 2丛骆骆.依那普利——对心血管疾病的治疗作用和其药理学特征[J].航空航天医药,1993,4(4):256-256. 被引量:1
  • 3GRADMAN AH,CUTLER NR, DAVIS PJ, et al. Combined enalapril and felodipine extended release (ER) for systemic hypertension [J]. Am J Cardiol, 1997, 79(4) : 431-435.
  • 4MIGLIORANCA LH,BARRIENTOS-ASTIGARRAGA RE, SCHUG BS, et al. Felodipine quantificcation in human plasma by high-performance liquid chromatography coupled to tandem mass spectrometry[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2005, 814(2): 217-223.
  • 5PORTOLES A, TERLEIRA A, ALMEIDA S, et ol. Bioequivalence study of two formulations of enalapril, at a single oral dose of 20 mg(tablets) : a randomized, two-way, open-label, crossover study in healthy volunteers[J]. Curr Ther Res, 2004, 65 (1): 34-46.
  • 6宋金辉,邹春雨,闫宏伟,王坤正,李政东,王雪峰.SD大鼠骨代谢与非洛地平的干预[J].中国组织工程研究与临床康复,2007,11(36):7190-7194. 被引量:3
  • 7袁新荣,李英勇,李红薇.不同疗法对去卵巢大鼠骨质疏松预防作用的比较[J].广东医学院学报,2007,25(4):387-390. 被引量:4
  • 8贾经汉,邱新建,陈志坚.骨质疏松动物模型的研究进展[J].中国康复医学杂志,2007,22(8):765-768. 被引量:22
  • 9Gu Q, Chen X, Zhong D, et al. Simultaneous determination of enalapril and enalaprilat in human plasma by liquid chromatography-tandem mass spectrometry [ J ]. J Chroma- togr B Analyt Technol Biomed Life Sci,2004,813(1/2) : 337-342.
  • 10Lu S, Jiang K, Qin F, et al. Simultaneous quantification of enalapril and enalaprilat in human plasma by high-per- formance liquid chromatography-tandem mass spectrome- try and its application in a pharmacokinetic study [ J ]. J Pharm Biomed Anal,2009,49( 1 ) :163-167.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部